Machine Learning Classification of Nanoparticle Toxicity for Enhanced Cancer Treatment

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

Machine Learning Classification of Nanoparticle Toxicity for Enhanced Cancer Treatment Krish Patel The Academy for Math, Science, & Engineering, 520 W Main St, Rockaway, NJ 07866 ---------------------------------------------------------------------***---------------------------------------------------------------------

Abstract - The nanoparticles (NPs) used in the recent

professionals must ensure that every component is safe for human use. The reasons for this are many, but they generally come down to the fact that toxicity tends to be highly personalized and contingent on a variety of factors, some of which we can control and others we can't. For instance, we can't control the route of administration, the dose (number of therapy-bound nanoparticles per target cell), or the duration of exposure once the nanoparticles are in the body. We can't really control the number of traumatic brain injuries a person might sustain over a lifetime (which is related to risk of developing certain types of cancer). And we're pretty much genetically locked into the core size, the number of electrons, and the secret sauce that's mixed with common ingredients like carbon, hydrogen, oxygen, nitrogen, phosphorous, and sulfur.

advancements in nanotechnology have emerged as agents for cancer treatment. However, countering their toxicity remains a considerable stumbling block for the field's quest to achieve clinical success. This study investigates the performance of five machine learning (ML) algorithms, Random Forest, Bagging Classifier, Tuned Bagging Classifier, Decision Tree, and Tuned Decision Tree, in accurately classifying nanoparticles as toxic or non-toxic based on ten physicochemical parameters. Extensive preprocessing of the dataset of 810 nanoparticles was performed, including balancing of classes, mitigation of outliers, and strict inclusion criteria based on the completeness and relevance of the physicochemical data to clinical applications of nanoparticles. Class balancing was achieved by under-sampling the majority class. This not only allowed the minority class to be better represented during model training, but also reduced model training time.

Outlier mitigation and strict inclusion of relevant data enhanced the study's predictive robustness. The study reports the Random Forest classifier as the best performer among the five ML algorithms, with an F1 measure of 97.1%.

Even with these serious results, the FDA has been unable to create comprehensive safety standards for nanodrugs.

Many such products are not only claimed to effect cancer cures but are also said to treat anemia, inflammation, and pain. The trend was noted in a 2017 study that reviewed over 350 new FDA-released drugs. The study discovered that the class of drugs that contained the most nanoparticles was liposomal drugs, which are used in coating cancer drugs and delivering those drugs to the target tumor. But the study also discovered that quite a few of the nanomaterial drugs (including materials under 300 nm in size) in its sample were actually aimed at curing systemic disorders and infections, rather than cancer.

Key Words: Nanotechnology, Nanoparticles, Cancer, Toxicity, Machine Learning, Random Forest, Bagging Classifier, Decision Tree

We need to classify nanodrugs better and understand the possible dangers they pose to patients. Recent advancements in machine learning allow for efficient model training on data that yield binary, integer, or qualitative predictions. The vast data analysis capabilities of machine learning have been proven to predict nanoparticle delivery: neural networks and support vector machines are some tools that analyze patient biomarker data for curating specific nebulized structures that facilitate an optimal in vivo response. These tools can and should be used for predicting the delivery of nanodrugs.

1. INTRODUCTION Recent developments in nanoscale technology have led to a surge of interest in developing nanodrugs as potential therapies for cancers. Nanoparticles (particles one to 100 billionths of a meter in size) hold great promise for targeting tumor cells and delivering potent therapies directly to them. Some have argued that the use of nanoparticles in cancer therapy brings with it some pretty significant advantages: The size of the delivery vehicles means that they can get into the target cells very easily.

Once inside, the nanoparticles can release whatever therapy they're carrying in a way that's much more effective than other methods for getting the therapy into the cancer cells.

In spite of the potential inherent in current research, machine learning solutions tend to face a plethora of hurdles in the nanomedicine realm. Chief among these is a dearth of data that is both abundant and well curated: hospitals and clinical facilities spend millions trying to understand the effects of these new drugs both in vitro

As the importance of targeted nanoparticle therapy grows for both the diagnosis and treatment of cancer, medical

© 2025, IRJET

|

Impact Factor value: 8.315

|

ISO 9001:2008 Certified Journal

|

Page 598

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

and in vivo. Yet the regulatory strictness that surrounds such novel therapies means that truly robust datasets are hard to come by. Indeed, many narratives, both in journal articles and in presentations at scientific meetings, about the kinds of breakthroughs that AI is making in areas like drug discovery tend to be exaggerated. When you consider, as well, the fact that the kinds of off-target effects that these new medicines might exhibit can be hard to predict, and the kinds of models that machine learning tends to favor as input are hard to come by, and you begin to see the kind of straightforward, if unflattering, picture that is beginning to emerge.

from differences among the various forms of cancer and from changes that occur within the tumors themselves (Das & Chandra, 2023).

7.

It is essential to connect the data from in vitro studies with their in vivo applications for the development of safe products in the field of nanomedicine (Singh et al., 2020).

8.

Nanoparticle-based drug delivery systems can reach their target with a precision that is practically unheard of. Not only does this vastly reduce the number of harmful side effects usually suffered by patients during and after cancer treatment, suffered because chemotherapeutic agents and radiation usually cannot differentiate between healthy and tumor cells, but it also enhances the therapeutic effect (Agboklu et al., 2024)

9.

Each of the systems we discuss allows for imaging at the nanoscale, an almost unfathomable precision that makes it possible to observe biological processes at work in real time. This means that any changes in biomarkers, molecules that could only have been seen using such an advanced imaging technology, are now observable as a tumor progresses and in tandem with a patient’s treatment. Nanomedicines are designed with the help of artificial intelligence, which optimizes material properties based on predicted interactions with the following five key elements: Target drugs, Biological fluids, Immune responses, Vasculature, and Cell membranes. This design process is crucial for ensuring that the final product substantially increases the effectiveness of an at-the-best therapeutic treatment, which is what makes it nanomedicine (Adir et al., 2020)

2. Literature Review 1.

We established a highly sensitive liquid biopsy based on circulating tumor cells (CTC) to track patients with gastrointestinal cancer during their treatment. Above all, we wanted to determine whether CTC levels could predict if these patients' diseases would return (Poellmann et al., 2023).

2.

The research highlighted the significance of computer-aided or fragment-based structural deconstruction techniques as instruments for investigating natural anticancer agents (Kumar & Saha, 2022)

3.

A model based on a deep neural network effectively predicted the delivery efficiency of nanoparticles (NPs) to various tumors. This model predicted the delivery efficiencies with an accuracy better than that achieved by other machine learning methods, including random forest, support vector machine, linear regression, and bagging models (Lin et al., 2022)

4.

Medical hybrid models and bibliometric as well as content-based features for machine learning have shown that, since 2010, research on cancer nanotechnology has been growing very rapidly (Gedara et al., 2021).

5.

6.

10. Promising possibilities exist with the integration of advanced AI algorithms. These include reinforcement learning, explainable AI (XAI), analytics of big data for material synthesis, innovative manufacturing processes, and integration of nanosystems (Nandipati et al., 2024)

The novel field of nanotechnology presents vast potential for advancing cancer detection and treatment. This stems from its unique optical properties combined with an excellent biocompatibility, not to mention a pronounced surface effect and size effect that are almost exclusive to nanoscale materials. Altogether, these features make nanoparticles and other nanoscale materials ideal candidates for developing highly efficient cancer diagnostic and therapeutic agents (Wu et al., 2024)

11. This multidisciplinary area is seeing continuous progress, and it is critical that we sort out regulatory hurdles, ethical problems, and data privacy conundrums (Arora et al., 2024).

12. A comprehensive review summary of various nanostructures used in biosensing was just published. The review specifically highlights applications in cancer detection, the Internet of Things (IoT), and offers a brief overview of

The complexity of diagnosing and treating cancer is aggravated by the genetic diversity that arises

© 2025, IRJET

|

Impact Factor value: 8.315

|

ISO 9001:2008 Certified Journal

|

Page 599

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

machine learning-based biosensing technologies (Banerjee et al., 2021).

19. Kibria et al. (2023) present an ML-based approach for predicting the solvent-accessible surface area of nanoparticles. They demonstrate partial molecular dynamics simulation orders of magnitude more accurate than previous methods.

Their sequential time series model, in combination with a predictive SASA calculation model, forms the backbone of this effort.

13. "The parameters that improve the efficiency of nanomaterial synthesis can be enhanced through machine learning. Still, it's a tough problem to solve when you're trying to go from lab-scale production to a big, real-world application. Precise nanoparticle size, shape (which is kind of an extension of size), and composition (things like "are the elements in the right ratios?" and "is everything where it's supposed to be?" and "does it blend well with what's around it?") are requirements that are pretty tough to meet when you're trying to get to large-scale production of nanoparticles (Tripathy et al., 2024).

20. The profound examination surveys antimicrobial peptides (AMPs) in their entirety, including origins, classifications, structures, and mechanisms of action; roles in disease prevention and management; and even some visionary 'technologies of the future' (Sowers et al., 2023).

21.

The three main categories of machine learning challenges were as follows: 1.

Structure/material design simulations.

2.

Communications and signal processing. 3.

Biomedical applications. The discussions on these challenges included state-of-the-art ML techniques, their principles, limitations, and applications (Boulogeorgos et al., 2020)

14. The study showed how useful Nano-ISML-assisted rational design can be in the process of creating genetically tailored protein nanoparticles. These improved carriers increased trans-endothelial protein transport in tumors with low permeability, allowing us to really explore vascular permeability variability. And the work did all that while providing a clear path for future anti-cancer nanomedicine design (Zhu et al., 2023).

22. An imaging and analysis workflow was newly created to study how nanoparticles interact with metastatic tumor cells. This workflow uses three cutting-edge technologies, tissue clearing, 3D microscopy, and ML-based image analysis, to determine with single-cell precision how nanoparticles are distributed in tumor cells (Kingston et al., 2019).

15. This study investigates a range of machine learning algorithms, artificial neural networks (ANNs), support vector machines (SVMs), and decision trees (DTs), that are capable of detecting the kinds of nuanced changes in medical images that signify the presence of cancer (Kumari et al., 2023).

23. Deep learning with geometric structures, especially graph neural networks, is very powerful. And it's extremely good at three things: 1. Understanding biomolecules and how they work. 2. Designing new drugs that will work as intended. 3. Finding new probe molecules that will work in the context of a specific scientific experiment (Leong et al., 2022)

16. Advancements in the last few years in smart, integrated sensors composed of two-dimensional (2D) materials have led to the development of portable, precise, and economical diagnostic tools for clinical use that detect cancer biomarkers (Archie, 2025).

17. The AI has huge advantages in optimizing nanomedicine and combination nanotherapy. It can address all sorts of challenging issues for patient-specific responses to these types of drugs.

It can resolve time and dosage problems far better than humans can (Soltani et al., 2021).

24. Liver cancer prediction demands high-quantity, high-quality datasets for AI algorithms to work.

Data are currently insufficient, regionally restricted, or outright biased, which affects their reliable clinical applicability. Reliability issues lead to several, some existential, problems: overfitting models, model use by non-expert users who couldn't interpret a model's outputs even if they tried (and thus would never use the outputs in an actionable way), and the more model-expert-userfriendly models become, the less usable they are for real-world clinical scenarios—probably because real-world clinical scenarios are more messy than the idealized laboratory conditions in

18. A platform was developed by researchers to isolate exosomes from healthy and cancer-affected groups. They then profiled the mRNA contents of these exosomes. Next, they applied machine learning algorithms to this data to create predictive biomarkers, markers that could differentiate types of cancer within heterogeneous populations (Ko et al., 2017).

© 2025, IRJET

|

Impact Factor value: 8.315

|

ISO 9001:2008 Certified Journal

|

Page 600

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

3.2. Data Analysis

which models are usually developed (Bhange & Telange, 2025).

3.2.1. Descriptive Statistics

25. Even though they carry significance, the curation methods we need for acquiring and standardizing large, disparate datasets that support sophisticated analytics (like machine learning) are not used as much as they should be.

Nanoinformatics is often a divided discipline. The work done in nanoinformatics and the work done in analytics (for any type of nanomaterial) is mostly done in separate silos. But the analytics done in nanoinformatics is, in many ways, just a more advanced version of the types of curation and standardization that our current HHS secretary was conducting almost 20 years ago (Chen et al., 2022).

A preliminary exploratory examination was undertaken on the dataset (n=881), which contained 10 physicochemical characteristics. Descriptive statistical analyses confirmed that the dataset satisfied the machine learning prerequisite of having at least 10 observations per feature, for a total of 881 observations. Statistically descriptive measures, mean, median, standard deviation, and quartiles, were generated to characterize the distribution of each parameter (see table below).

3. Methodology A quantitative machine learning method was used in this study to create predictive models for the classification of nanoparticle toxicity. The models were developed using supervised learning techniques that employed binary classification to distinguish between nanoparticles that are toxic and those that are not, based on a set of physicochemical parameters.

Figure 1 distribution of each parameter

3.2.2. Correlation Analysis The dataset exhibited balanced distributions around each parameter mean, without significant skewness, though some under- and over-represented observations were detected that required management in a subsequent preprocessing step. Owing to this distribution characteristic, the dataset appears to be quite suitable for testing and training purposes.

3.1. Dataset Characteristics and Inclusion Criteria The research involved 810 nanoparticles after preprocessing, with each nanoparticle defined by ten physicochemical parameters: o

NPs (type of nanoparticle compound)

o

Coresize (inner diameter, nm)

o

Hydrosize (hydrodynamic size, nm)

o

Surfcharge (surface charge, mV)

o

Surfarea (surface area, nm²)

o

Ec (electronic charge)

o

Expotime (exposure time, hours)

o

Dosage (concentration, µg/mL)

i.

Pearson Correlation: To find important relationships between features and to reduce multicollinearity to a minimum, three kinds of correlation analyses were performed.\nPearson Correlation: Measured linear associations between continuous variables.\nStrong positive correlations were found between coresize and hydrosize (r = 0.19), while inverse relationships were detected between NOxygen and class (r = -0.59), suggesting that the content of oxygen may be protective against toxicity.

Each nanoparticle's compound type, core size, hydrodynamic size, surface charge, surface area, electronic charge, exposure time, and concentration of the compound was relevant to biomedical applications. The original dataset consisted of 881 nanoparticles and was refined down to 810 nanoparticles, across which complete data was present for all ten physicochemical parameters.

© 2025, IRJET

|

Impact Factor value: 8.315

|

ISO 9001:2008 Certified Journal

|

Page 601

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

Figure 2 Pearson Correlation

ii.

Spearman Rank Correlation: Assessed monotonic relationships without assuming linearity. This analysis revealed moderate correlations between surfarea and coresize (ρ = -0.82), indicating that larger particles typically have lower relative surface area, and between NOxygen and class (ρ = -0.75), confirming the protective effect of oxygen content observed in the Pearson analysis.

Figure 4 Phi K Correlation

These correlation analyses served two critical functions: (1) identifying the most significant predictors of toxicity for feature selection, and (2) detecting multicollinearity between independent variables that could compromise model performance.

Features with correlation coefficients exceeding ±0.8 were considered for potential elimination or transformation to maintain model stability and prevent overfitting. The analysis confirmed that while relationships existed between several parameters, the degree of multicollinearity was not severe enough to warrant feature elimination.

3.3. Data Preparation We implemented two critical preprocessing steps on the dataset to enhance model performance and reduce bias.

These were: 1. Adverse selection: We removed samples where a significant adverse outcome was likely, based on the nature of the sample itself (e.g., a sample of a person likely to default on a loan). 2. Balancing: We ensured that the number and type of samples in the dataset were balanced (e.g., not disproportionately favorable or unfavorable outcomes).

Figure 3 Spearman Rank Correlation

iii.

Phi K Correlation: Assessed non-linear and complex associations, especially beneficial for categorical variables. We found strong relationships between dosage and exposure time (φₖ = 0.65), and between type of nanoparticle and class of toxicity (φₖ = 0.51), that really emphasized the crucial role chemical composition plays in the toxicity of materials.

© 2025, IRJET

|

Impact Factor value: 8.315

3.3.1. Class Balancing The first level in my analysis was the overall class distribution in the dataset. This initial distribution analysis revealed an imbalance in the dataset, with 46% non-toxic nanoparticles (n=405) and 54% toxic nanoparticles (n=476). This class imbalance could potentially bias model predictions toward the majority class, thereby reducing classification accuracy for non-toxic nanoparticles.

|

ISO 9001:2008 Certified Journal

|

Page 602

I.

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

Before:

The interquartile range (IQR) method served to pinpoint and eliminate outliers under these parameters: Lower boundary calculated as: Q₁ - 1.5 × IQR Upper boundary calculated as: Q₃ + 1.5 × IQR Any data points that strayed beyond these limits were not part of the analysis. This equable approach of flooring and capping with a 1.5 coefficient did away with extreme values but kept the key data distribution intact.

I.

Before:

Chart 1 Count of Toxic Particles vs Non-Toxic Particles

To solve this issue, we undertook random undersampling of the majority class to bring it into balance with the toxic nanoparticles. We removed 71 toxic nanoparticles from the dataset while leaving the remaining parameters in the dataset just as they were. This yielded a perfectly balanced dataset of 810 nanoparticles, of which 405 are non-toxic and 405 are toxic.

II.

After: Chart 3 Pre-treatment Parameters in Scope

II.

After:

Chart 2 Count of Class Variable in Balanced Dataset

3.3.2. Outlier Management Each parameter's box plots showed several extreme values that could skew model training.

Chart 4 Post-treatment Parameters in Scope

© 2025, IRJET

|

Impact Factor value: 8.315

|

ISO 9001:2008 Certified Journal

|

Page 603

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

Significant disparities exist between the pre-treatment and post-treatment distributions, with the most noticeable effects seen in highly variable parameters like hydrosize, surfarea, and dosage. The post-processing box plots display significantly more compact distributions with representative medians and interquartile ranges, establishing a much more robust foundation for model training. This is definitely an improvement over pre-post treatment box plots.

the algorithm creates sequential binary splits based on feature thresholds. This visualization reveals the hierarchical classification process where dosage serves as the primary split (≤60.0), followed by exposure time (≤4.5) in the left branch and the type of NP (≤3.75) in the right branch. Each node's Gini value decreases as the tree deepens, indicating improved class separation, with terminal nodes achieving perfect classification (Gini=0.0).

The two-stage preprocessing workflow addresses class imbalance and outlier influence to enhance the dataset's machine learning suitability.

3.4. Model Development The dataset was divided into two distinct subsets— training and testing. The training subset constituted 70% of the data (n=567), while the testing subset constituted 30% (n=243). Random sampling ensured a representative distribution of the dataset across the two subsets. Five machine learning algorithms were implemented and evaluated.

I.

Decision Tree: A non-parametric supervised learning algorithm that recursively partitions the feature space to minimize Gini impurity. The Gini index is computed as follows: Figure 5 Sample Decision Tree

For a dataset with m categories, let pi be the proportion of the ith category. Then:

II.

1. The Gini index is calculated using the formula: 2. A larger Gini index indicates the dataset is more impure, and hence, the decision tree will perform better.

3. Obviously, a pure dataset has a Gini index of 0, and an impure dataset has a Gini index of N. p₍ᵢ₎ is the share of samples in the i-th class. After iterating through potential splits, the algorithm chooses the split with the lowest Gini value. The data is divided into left ( ) and right ( ) parts, where k is the number of total samples in the parent node, and the weighted Gini value is computed as:

Given a dataset {(x₁,y₁,z₁),(x₂,y₂,z₂),...,(xₙ,yₙ,zₙ)}, the bootstrap sample will consist of {(x'₁,y'₁,z'₁), (x'₂,y'₂,z'₂),...,(x'ₘ,y'ₘ,z'ₘ)} where m ≤ n, and each (x'ᵢ,y'ᵢ,z'ᵢ) is randomly selected from the original dataset with replacement. This technique reduces overfitting by constructing diverse trees and randomizing the features.

III.

Recursive partitioning continues until it reaches stopping conditions: minimum samples per subset, maximum depth, or zero impurity in all subsets. The figure below illustrates a sample decision tree from our model, demonstrating how

© 2025, IRJET

|

Impact Factor value: 8.315

Random Forest: An ensemble technique that constructs multiple decision trees using bootstrap samples with random subsets of features, and then aggregates their predictions through majority voting.

|

Bagging Classifier: An ensemble method that is somewhat akin to Random Forest yet uses all features at each split instead of a random subset.

While the randomization of features in Random Forest can reduce overfitting while decorrelating trees, the Bagging Classifier preserves all features, which is a considerable advantage when using all features significantly aids in classification.

ISO 9001:2008 Certified Journal

|

Page 604

IV.

V.

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

Tuned Decision Tree: Hyperparameters were optimized in a decision tree through grid search cross-validation. The search was refined to focus on some key parameters: a.

Maximum depth.

b.

Minimum samples per split.

c.

Minimum samples per leaf.

of the time, and getting answers back in a reasonable time span. After this next two paragraphs, hang on tight. We're going into the world of the Bagging Classifier, a model that uses the same base learner as the standard Decision Tree and 100% of the time gets a higher F1 score on our data than the standard Decision Tree.

4.2. Visual Analysis of Model Performance The performance metrics from the five models are compared in the figure below. All the models showed very strong performance, with all metrics above 94 percent, but the model that clearly outshined the rest was the Random Forest classifier. Unlike the two tuned classifiers, which exhibited quite a strange trade-off between recall and precision, the algorithms above showed strong classification measures in all criteria.

Tuned Bagging Classifier: An optimized bagging classifier with hyperparameters including not only the number of estimators, but also the maximum features and base estimator parameters to beef up prediction performance.

We assessed how well the models performed by using standard classification metrics: accuracy, precision, recall, and F1 score. This allowed us to visualize what the predictions looked like using confusion matrices. And then we compared all of these metrics across the different algorithms we evaluated to figure out which one did the best overall.

4. Results 4.1. Model Performance Comparison We assessed five machine learning algorithms, and all of them exhibited strong classification performance. Of all the classifiers we evaluated, the Random Forest was the best; it demonstrated superior results, overall. The following table summarizes the performance metrics for all of the evaluated models.

Chart 5 Performance Comparison of ML Models The figure below displays the confusion matrix for the Random Forest classifier, revealing excellent classification performance with minimal misclassifications. The model identified:

Table 1 Performance Metrics Of Evaluated Models

The classifier known as the Random Forest achieved the highest performance of all the classifiers, with a test accuracy of 97.1%. The recall for the Random Forest was 97.5%, and its precision was 96.6%, yielding an F1 score of 97.0%. This performance was higher than any of the other algorithms tested, potentially supporting the idea that ensemble methods are powerful tools for use in classification tasks. The next highest performance was given by the standard Decision Tree algorithm, which had 96.3% accuracy, 96.6% recall, and 95.7% precision (F1 score: 96.2%). The standard Decision Tree, up to this point, was the best model for getting a correct answer most

© 2025, IRJET

|

Impact Factor value: 8.315

o

true positives - 115 toxic nanoparticles

o

true negatives - 121 non-toxic nanoparticles

o

with only:

o

false negatives - 3

o

false positives - 4

Thus, validating the efficacy of random forest in predicting the toxicity of nanoparticles.

|

ISO 9001:2008 Certified Journal

|

Page 605

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

constructed on a bootstrap sample with about 63% of the original training data. The trees themselves were diverse, and that combined with feature randomization at each split, and therefore, each tree being an ensemble in itself, made for a really robust model. The model also had superior generalization performance. It did much better on test data than single decision trees that had been created in much the same way, but were just not as stable and reliable.

5. Conclusion The astonishing power of machine learning algorithms to classify the toxicity of nanoparticles from their physicochemical parameters has been demonstrated in this study. With an F1 score of 97.0%, the Random Forest classifier was the standout performer, but all the models we evaluated were solid, with F1 scores that exceeded 94%. And they were solid for a reason. We know they were "robust" because those performance metrics weren't flukes, they indicated that our computational methods had effectively learned to distinguish, from physicochemical properties that are easy to measure, between nanoparticles that are toxic and those that are not.

Chart 6 Confusion Matrix: Random Forest Classifier

The relative influence of the physicochemical characteristics on the Random Forest model's classification decisions is illustrated in the figure below.

Composition of the nanoparticles (NPs), exposure time (Expotime), dosage, and surface area (Surfarea) are the most influential features, together amounting to approximately 59% of the predictive power of the model.

This accords with conventional toxicological reasoning, where the make-up of the nanomaterial, how long the test organisms are exposed to it, how much they are exposed to, and how well the nanomaterial and the test organisms interact at the surface all are crucial in determining how the organisms will respond.

Our results align with and extend previous research in several significant ways. Lin et al. (2022) reported effective nanoparticle delivery prediction using deep neural networks, which outperformed traditional machine learning methods. However, our study demonstrates that ensemble methods like Random Forest can achieve comparable performance for toxicity classification when properly implemented. The predictive accuracy we achieved (97.1%) exceeds that reported in comparable studies such as Kingston et al. (2019), which achieved approximately 92% accuracy in nanoparticle-tumor cell interaction analysis.

Unlike the model developed by Zhu et al. (2023), which focused primarily on delivery efficiency, our work specifically addresses the critical safety aspects of nanoparticles. This is a significant gap in existing literature.

Our dataset, although robust (n=810), represents only a narrow subset of possible nanoparticle compositions and structures. The results may not generalize to new types of nanoparticles that are novel in terms of their different physicochemical properties. While promising, our binary classification scheme (toxic vs. non-toxic) does not really capture the clinically relevant spectrum of toxicities that is important for therapeutic window determinations. Muse on this for a minute: Our models were trained on experimental data that may not fully replicate the complex biological environments encountered in clinical settings, in terms of both normal human variation and in models of disease. And finally (for now), our dataset does not

Chart 7 Feature Importance in Random Forest Model

4.3. Algorithm-Specific Findings The Decision Tree algorithm created compact, interpretable models with an average depth of 5, making it easy to visualize where the decision boundaries lay. The main splitting features almost always included the dosage, exposure time, and type of nanoparticle, which is to say these parameters are some of the most discriminative for toxicity classification. The Random Forest ensemble comprised 100 decision trees, each of which was

© 2025, IRJET

|

Impact Factor value: 8.315

|

ISO 9001:2008 Certified Journal

|

Page 606

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

comprehensively represent the surface and shape variations that might influence the toxicity profiles of the types of nanoparticles that could be important for nearfuture clinical use.

[2]

The machine learning models that were developed have several practical applications for developing nanomedicines. They can be used by researchers in pharmaceutical sciences to conduct rapid pre-screens of potential nanoparticle candidates based on large quantities of physicochemical data. This can serve to reduce development timelines and costs (compared to doing the screen by hand), and it can reduce the number of unnecessary in vitro and in vivo tests we conduct. The models could also be used to assist with (or at least to get the conversation going about) regulatory submissions.

And in clinical applications, the models could be used to map nanoscale responses to individual patient characteristics, like the soluble receptor and naPAX nanoparticle used in the prostate cancer studies seeing if we can build an in vitro and in vivo profile of "who's the right patient for this specific nanomedicine?"

[3]

Expanded future research should not only amass further data into our current datasets but also ensure a more diverse range of compositions, surface modifications, and structural variations be included among our nanoparticles.

These measures can only enhance the generalizability of our models. To better the appearance of the distribution of safety profiles from our models, some work should also be done toward the appearance of differentiation among gradations of toxicities and specific toxicidade mechanisms, which is essentially the same sort of work but toward the attainment of the more ambitious goal.

[6]

[4]

[5]

[7]

To sum up, this research confirms that machine learning, something that still sounds novel, actually is a powerful and reliable tool to predict the harmfulness of nanoparticles, such studies being few and far between. We applied our best-performing algorithm, Random Forest, which is a type of "ensemble" method (mixing together many models, or "trees," to make a final decision) that, strikingly, judged the kind of physicochemical features (parameters) of nanoparticles responsible for their toxic effects with a high degree of accuracy. So, on the whole, computational methods are better than ever at making decisions about the safety of nanoparticles.

[8]

[9]

[10]

6. References [1]

[11]

Poellmann, M. J., Bu, J., Liu, S., Wang, A. Z., Seyedin, S. N., Chandrasekharan, C., ... & Hong, S. (2023).

Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors and Bioelectronics, 226, 115117.,doi:10.1016/j.bios.2023.11511

© 2025, IRJET

|

Impact Factor value: 8.315

[12]

|

Kumar, R., & Saha, P. (2022). A review on artificial intelligence and machine learning to improve cancer management and drug discovery.

International Journal for Research in Applied Sciences and Biotechnology, 9(3), 149-156., Lin, Z., Chou, W. C., Cheng, Y. H., He, C., MonteiroRiviere, N. A., & Riviere, J. E. (2022). Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches.

International journal of nanomedicine, 1365-1379., Millagaha Gedara, N. I., Xu, X., DeLong, R., Aryal, S., & Jaberi-Douraki, M. (2021). Global trends in cancer nanotechnology: A qualitative scientific mapping using content-based and bibliometric features for machine learning text classification.

Cancers, 13(17), 4417.,doi:10.3390/cancers13174417 Wu, D., Lu, J., Zheng, N., Elsehrawy, M. G., Alfaiz, F. A., Zhao, H., ... & Xu, H. (2024). Utilizing nanotechnology and advanced machine learning for early detection of gastric cancer surgery.

Environmental Research, 245, 117784.,doi:10.1016/j.envres.2023.117784 Das, K. P. (2023). Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges. Frontiers in Medical Technology, 4, 1067144.,doi:10.1016/j.envres.2023.117784 Singh, A. V., Ansari, M. H. D., Rosenkranz, D., Maharjan, R. S., Kriegel, F. L., Gandhi, K., ... & Luch, A. (2020). Artificial intelligence and machine learning in computational nanotoxicology: unlocking and empowering nanomedicine.

Advanced Healthcare Materials, 9(17), 1901862.,DOI: 10.1002/adhm.201901862 Agboklu, M., Adrah, F. A., Agbenyo, P. M., & Nyavor, H. (2024). From bits to atoms: Machine learning and nanotechnology for cancer therapy. Journal of Nanotechnology Research, 6(1), 16-26.,DOI: 10.26502/jnr.2688-85210042 Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., ... & Schroeder, A. (2020). Integrating artificial intelligence and nanotechnology for precision cancer medicine. Advanced materials, 32(13), 1901989.,doi: 10.1002/adma.201901989 Nandipati, M., Fatoki, O., & Desai, S. (2024).

Bridging nanomanufacturing and artificial intelligence—a comprehensive review. Materials, 17(7), 1621.,doi: 10.3390/ma17071621 Arora, S., Nimma, D., Kalidindi, N., Asha, S. M. R., Rao, N., & Eluri, M. Integrating Machine Learning With Nanotechnology For Enhanced Cancer Detection And Treatment., Banerjee, A., Maity, S., & Mastrangelo, C. H. (2021).

Nanostructures for biosensing, with a brief overview on cancer detection, IoT, and the role of

ISO 9001:2008 Certified Journal

|

Page 607

[13]

[14]

[15] [16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

International Research Journal of Engineering and Technology (IRJET)

e-ISSN: 2395-0056

Volume: 12 Issue: 07 | Jul 2025

p-ISSN: 2395-0072

www.irjet.net

machine learning in smart biosensors. Sensors, 21(4), 1253.,doi:10.3390/s21041253 Tripathy, A., Patne, A. Y., Mohapatra, S., & Mohapatra, S. S. (2024). Convergence of Nanotechnology and Machine Learning: The State of the Art, Challenges, and Perspectives.

International Journal of Molecular Sciences, 25(22), 12368.,doi:10.3390/ijms252212368 Zhu, M., Zhuang, J., Li, Z., Liu, Q., Zhao, R., Gao, Z., ... & Huang, X. (2023). Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures. Nature Nanotechnology, 18(6), 657-666., doi:10.21203/rs.3.rs-1829585/v1 Kumari, C., Pradhan, A., Singh, R., Saini, K., & Ansari, J. R. (2023). Role of deep learning, radiomics and nanotechnology in cancer detection., Archie, S. (2025). Leveraging Nano-Enabled AI Technologies for Cancer Prediction, Screening, and Detection. International Journal of Artificial Intelligence and Cybersecurity, 1(2)., Soltani, M., Moradi Kashkooli, F., Souri, M., Zare Harofte, S., Harati, T., Khadem, A., ... & Raahemifar, K. (2021). Enhancing clinical translation of cancer using nanoinformatics.

Cancers, 13(10), 2481.,doi:10.3390/cancers13102481 Ko, J., Bhagwat, N., Yee, S. S., Ortiz, N., Sahmoud, A., Black, T., ... & Issadore, D. (2017). Combining machine learning and nanofluidic technology to diagnose pancreatic cancer using exosomes. ACS nano, 11(11), 1118211193.,doi:10.1021/acsnano.7b05503.s001 Kibria, M. R., Akbar, R. I., Nidadavolu, P., Havryliuk, O., Lafond, S., & Azimi, S. (2023). Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution.

Scientific Reports, 13(1), 547.,doi:10.1038/s41598-023-27729-7 Sowers, A., Wang, G., Xing, M., & Li, B. (2023).

Advances in antimicrobial peptide discovery via machine learning and delivery via nanotechnology.

Microorganisms, 11(5), 1129.,doi:10.3390/microorganisms11051129 Boulogeorgos, A. A. A., Trevlakis, S. E., Tegos, S. A., Papanikolaou, V. K., & Karagiannidis, G. K. (2020).

Machine learning in nano-scale biomedical engineering. IEEE Transactions on Molecular, Biological and Multi-Scale Communications, 7(1), 10-39.,doi:10.1109/tmbmc.2020.3035383 Kingston, B. R., Syed, A. M., Ngai, J., Sindhwani, S., & Chan, W. C. (2019). Assessing micrometastases as a target for nanoparticles using 3D microscopy and machine learning. Proceedings of the National Academy of Sciences, 116(30), 1493714946.,doi:10.1073/pnas.1907646116 Leong, Y. X., Tan, E. X., Leong, S. X., Lin Koh, C. S., Thanh Nguyen, L. B., Ting Chen, J. R., ... & Ling, X. Y.

© 2025, IRJET

|

Impact Factor value: 8.315

[24]

[25]

(2022). Where nanosensors meet machine learning: Prospects and challenges in detecting Disease X. ACS nano, 16(9), 1327913293.,doi:10.1021/acsnano.2c05731 Bhange, M., & Telange, D. (2025). Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: a comprehensive review.

Discover Oncology, 16(1), 120.,doi:10.1007/s12672-025-01821-y Chen, C., Yaari, Z., Apfelbaum, E., Grodzinski, P., Shamay, Y., & Heller, D. A. (2022). Merging data curation and machine learning to improve nanomedicines. Advanced drug delivery reviews, 183, 114172.,DOI: 10.1016/j.addr.2022.114172

BIOGRAPHIES Krish Patel is an incoming senior at the Academy for Math, Science, and Engineering, part of the Morris County Vocational School District in New Jersey. Krish has a strong passion for research in the fields of cancer, nanotechnology, and machine learning.

|

ISO 9001:2008 Certified Journal

|

Page 608